Brain tumors & immune-checkpoint inhibitors

Uri Tabori, MD, of the Hospital for Sick Children, Toronto, Canada, explains the use of immune-checkpoint inhibitors for brain tumors and the importance of molecular screening prior to therapy. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.